Skip to content
MEO NextGenDeveloper StudioDEV
  1. Dashboard
  2. Questions
  3. SBA
  4. Q450
SBA

SBA — Single Best Answer · Review

Question 450

Pharmacology → General

NextGen Workflow Status Needs Review
SQL status generated
Destination Site
Type SSBA
UUID dd22e219-404a-46ae-b653-ca5e4b506827

Classification

Speciality
Obstetrics and Gynaecology
Group
Basic
Title
Pharmacology
Topic
General
Subtopic 1
Antidepressant Drugs
Subtopic 2
Reversible MAO-A inhibitors
Subtopic 3
Tyramine response
Question Type
SBA

Question

SSBA
Question Header
A patient requires an antidepressant acting through monoamine oxidase inhibition, but minimisation of dietary tyramine interaction is particularly important. Which pharmacological profile best characterises reversible MAO-A inhibitors?
Question Stem
Select the single best answer.

Options

A Marked potentiation of dietary tyramine requiring strict dietary restriction
B Minor potentiation of the pressor response to ingested amines with no dietary restriction required
C Predominant noradrenaline reuptake blockade with pronounced antimuscarinic effects
D Irreversible dopamine receptor blockade with extrapyramidal adverse effects
E Selective serotonin reuptake inhibition with obligatory tyramine avoidance

Explanation

Reversible inhibitors of MAO-A, including moclobemide and clorgyline, produce only minor potentiation of the pressor response to ingested amines; consequently dietary restrictions are not required. They also lack several adverse effects associated with typical tricyclic antidepressants.

Option Validity

A) Marked tyramine potentiation is characteristic of the conventional MAO inhibitors seen with conventional MAO inhibitors rather than reversible MAO-A inhibitors.

C) Noradrenaline reuptake blockade is a tricyclic antidepressant mechanism and is not the defining mechanism of RIMAs.

D) Dopamine receptor blockade is the principal mechanism of antipsychotic drugs.

E) Selective serotonin reuptake inhibition characterises SSRIs and is not the mechanism defining RIMAs.

Further Reading

Saxena R. Textbook for MRCOG-1. Chapter 12: Pharmacology. Antidepressant Drugs, p.346.

Source & metrics

Authored Difficulty
5.00
Evaluation Score
—
Destination
Site
Source
Saxena - MRCOG-1 Basic Sciences - Pharmacology - General
Source Section
Antidepressant Drugs
Source Locator
Chapter 12, p.346
Updated
2026-10-06 01:57:35
Difficulty Factor
Not available yet
Attended Users
No candidate-attempt data yet
Review Question